ID: ALA5279874

Max Phase: Preclinical

Molecular Formula: C6H9N5S

Molecular Weight: 183.24

Associated Items:

Representations

Canonical SMILES:  CSC1=NNC2NN=C(C)C2=N1

Standard InChI:  InChI=1S/C6H9N5S/c1-3-4-5(9-8-3)10-11-6(7-4)12-2/h5,9-10H,1-2H3

Standard InChI Key:  IIMUZSBYIGPMFP-UHFFFAOYSA-N

Associated Targets(Human)

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 183.24Molecular Weight (Monoisotopic): 183.0579AlogP: -0.03#Rotatable Bonds: 0
Polar Surface Area: 61.14Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.06CX LogP: 1.20CX LogD: 1.20
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.55Np Likeness Score: -0.66

References

1. Alizadeh SR, Ebrahimzadeh MA..  (2021)  Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.,  223  [PMID:34147747] [10.1016/j.ejmech.2021.113537]

Source